KDELR2 promotes bone marrow mesenchymal stem cell osteogenic differentiation via GSK3β/β-catenin signaling pathway
In conclusion, KDELR2 promotes the osteogenesis of mBMSCs by regulating the GSK3β/β-catenin signaling pathway.
Source: Cell and Tissue Research - Category: Cytology Source Type: research
More News: Cytology | Orthopaedics | Osteogenesis Imperfecta (brittle bone disease) | Stem Cell Therapy | Stem Cells | Study